"10.1371_journal.pone.0099801","plos one","2014-06-27T00:00:00Z","Alexander J Probst; Giovanni Birarda; Hoi-Ying N Holman; Todd Z DeSantis; Gerhard Wanner; Gary L Andersen; Alexandra K Perras; Sandra Meck; Jörg Völkel; Hans A Bechtel; Reinhard Wirth; Christine Moissl-Eichinger","Institute for Microbiology and Archaea Center, University of Regensburg, Regensburg, Germany; Center for Environmental Biotechnology, Lawrence Berkeley National Laboratory, Berkeley, California, United States of America; Department for Bioinformatics, Second Genome Inc., South San Francisco, California, United States of America; Department of Biology I, Biozentrum, LMU Munich, Planegg-Martinsried, Germany; Department of Geomorphology and Soil Science, Technische Universität München, Center of Life and Food Sciences Weihenstephan, Freising, Germany; Advanced Light Source, Lawrence Berkeley National Laboratory, Berkeley, California, United States of America","Conceived and designed the experiments: AJP GB H-YNH CM-E. Performed the experiments: AJP GB GW AKP SM CM-E. Analyzed the data: AJP GB TZD GW JV. Contributed reagents/materials/analysis tools: GLA TZD HAB RW. Wrote the paper: AJP GB H-YNH CM-E.","TZD and AJP are paid employees of Second Genome, Inc. (www.secondgenome.com), patent on PhyloChip G3 pending. This does not alter adherence to PLOS ONE policies on sharing data and materials. Second Genome is a gastrointestinal therapeutics company with a pipeline of intestinal microbiome modulators that impact metabolic diseases and IBD. The publication of archaeal microbiome dynamics in sulfidic groundwater does not influence the value of any of Second Genomes therapeutic assets.","2014","06","Alexander J Probst","AJP",12,TRUE,4,6,5,4,TRUE,TRUE,FALSE,0,NA,FALSE
